.jpg)
Repatha - Evolocumab
Repatha, generic name evolocumab, is a medication used to lower LDL cholesterol levels in individuals with hypercholesterolemia or those at high risk of cardiovascular events. It belongs to a class of drugs called PCSK9 inhibitors, which work by increasing the liver's ability to remove LDL cholesterol from the blood. Repatha is typically administered via subcutaneous injection and can be used alone or in combination with other cholesterol-lowering medications. Common side effects include injection site reactions, flu-like symptoms, and upper respiratory tract infections. Repatha has been shown to reduce the risk of heart attacks, strokes, and cardiovascular-related deaths when used as part of a comprehensive treatment plan.
Drug Stopped - Causing neurological issues and the inability to walk
Drug interaction with PCSKP and causing (CIDP Chronic Inflammatory Demyelinating Polyneuropathy)
Experts Issue Caution for Evolocumab Following New Review of FOURIER Data; Amgen Disputes the Claims